Filing Details
- Accession Number:
- 0001209191-20-052400
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-29 20:07:38
- Reporting Period:
- 2020-09-29
- Accepted Time:
- 2020-09-29 20:07:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1678660 | Prelude Therapeutics Inc | PRLD | Pharmaceutical Preparations (2834) | 811384762 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1824631 | Christopher Pierce | C/O Prelude Therapeutics Incorporated 200 Powder Mill Road Wilmington DE 19801 | Evp And Chief Of Business Oper | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-29 | 3,750 | $19.00 | 3,750 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
